Literature DB >> 26880224

Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting.

Matthew J Baggott1, Jeremy R Coyle2, Jennifer D Siegrist3, Kathleen J Garrison4, Gantt P Galloway4, John E Mendelson4.   

Abstract

The drug 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy", "molly") is a widely used illicit drug and experimental adjunct to psychotherapy. MDMA has unusual, poorly understood socioemotional effects, including feelings of interpersonal closeness and sociability. To better understand these effects, we conducted a small (n=12) within-subjects double-blind placebo controlled study of the effects of 1.5 mg/kg oral MDMA on social emotions and autobiographical disclosure in a controlled setting. MDMA displayed both sedative- and stimulant-like effects, including increased self-report anxiety. At the same time, MDMA positively altered evaluation of the self (i.e. increasing feelings of authenticity) while decreasing concerns about negative evaluation by others (i.e. decreasing social anxiety). Consistent with these feelings, MDMA increased how comfortable participants felt describing emotional memories. Overall, MDMA produced a prosocial syndrome that seemed to facilitate emotional disclosure and that appears consistent with the suggestion that it represents a novel pharmacological class.
© The Author(s) 2016.

Entities:  

Keywords:  3,4-Methylenedioxymethamphetamine; anxiety; authenticity; ecstasy; emotion; entactogen; interpersonal; social

Mesh:

Substances:

Year:  2016        PMID: 26880224     DOI: 10.1177/0269881115626348

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  14 in total

1.  Altered Insula Connectivity under MDMA.

Authors:  Ishan C Walpola; Timothy Nest; Leor Roseman; David Erritzoe; Amanda Feilding; David J Nutt; Robin L Carhart-Harris
Journal:  Neuropsychopharmacology       Date:  2017-02-14       Impact factor: 7.853

2.  Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field.

Authors:  Franklin King; Rebecca Hammond
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-06-17

3.  MDMA does not alter responses to the Trier Social Stress Test in humans.

Authors:  Anya K Bershad; Melissa A Miller; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2017-04-21       Impact factor: 4.530

4.  Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs.

Authors:  Andrew Gaddis; Stephanie Lake; Kenneth Tupper; Ekaterina Nosova; Katrina Blommaert; Evan Wood; Kora DeBeck
Journal:  Drug Alcohol Depend       Date:  2018-09-12       Impact factor: 4.492

Review 5.  Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.

Authors:  Hans Emanuel Oeri
Journal:  J Psychopharmacol       Date:  2020-09-10       Impact factor: 4.153

Review 6.  Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships.

Authors:  Jason B Luoma; Ben Shahar; M Kati Lear; Brian Pilecki; Anne Wagner
Journal:  Hum Psychopharmacol       Date:  2021-11-05       Impact factor: 2.130

7.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

8.  3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Authors:  Marcela Ot'alora G; Jim Grigsby; Bruce Poulter; Joseph W Van Derveer; Sara Gael Giron; Lisa Jerome; Allison A Feduccia; Scott Hamilton; Berra Yazar-Klosinski; Amy Emerson; Michael C Mithoefer; Rick Doblin
Journal:  J Psychopharmacol       Date:  2018-10-29       Impact factor: 4.153

Review 9.  The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

Authors:  Anya K Bershad; Melissa A Miller; Matthew J Baggott; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2016-08-25       Impact factor: 4.153

10.  Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.

Authors:  Anna Borissova; Bart Ferguson; Matthew B Wall; Celia Ja Morgan; Robin L Carhart-Harris; Mark Bolstridge; Michael Ap Bloomfield; Tim M Williams; Amanda Feilding; Kevin Murphy; Robin J Tyacke; David Erritzoe; Lorna Stewart; Kim Wolff; David Nutt; H Valerie Curran; Will Lawn
Journal:  J Psychopharmacol       Date:  2020-06-15       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.